Atlas Trials

Flecainide Versus Amiodarone in the Cardioversion of Paroxysmal Atrial Fibrillation at the Emergency Department, in Patients With Coronary Artery Disease Without Residual Ischemia

Clinical trial NCT05549752 · RECRUITING

Trial details

NCT number
NCT05549752
Sponsor
Hippocration General Hospital
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Atrial Fibrillation ParoxysmalCoronary Artery Disease Without Residual Ischemia
Start date
2023-03-24
Primary completion
2025-12-30
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.